SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Lindahl Sofia)
 

Sökning: WFRF:(Lindahl Sofia) > (2005-2009) > The ATP-gated P2X1 ...

The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine

Grenegård, Magnus (författare)
Linköpings universitet,Farmakologi,Hälsouniversitetet
Vretenbrant-Öberg, Karin (författare)
Linköpings universitet,Klinisk kemi,Hälsouniversitetet
Nylander, Martina (författare)
Linköpings universitet,Farmakologi,Hälsouniversitetet
visa fler...
Désilets, Stéphanie (författare)
Linköpings universitet,Farmakologi,Hälsouniversitetet
Lindström, Eva G (författare)
Linköpings universitet,Farmakologi,Hälsouniversitetet
Larsson, Anders (författare)
Uppsala universitet,Institutionen för medicinska vetenskaper,Biokemisk struktur och funktion,Department of Medical Sciences, University Hospital, Uppsala SE-75105, Sweden
Ramström, Ida (författare)
Linköpings universitet,Farmakologi,Hälsouniversitetet,Landstinget i Östergötland
Ramström, Sofia (författare)
Linköpings universitet,Klinisk kemi,Hälsouniversitetet
Lindahl, Tomas L (författare)
Östergötlands Läns Landsting,Linköpings universitet,Klinisk kemi,Hälsouniversitetet
visa färre...
 (creator_code:org_t)
2008
2008
Engelska.
Ingår i: Journal of Biological Chemistry. - 0021-9258 .- 1083-351X. ; 283:27, s. 18493-18504
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Human platelets express protease-activated receptor 1 (PAR1) and PAR4 but limited data indicate for differences in signal transduction. We studied the involvement of PAR1 and PAR4 in the cross-talk between thrombin and epinephrine. The results show that epinephrine acted via alpha(2A)-adrenergic receptors to provoke aggregation, secretion, and Ca(2+) mobilization in aspirin-treated platelets pre-stimulated with subthreshold concentrations of thrombin. Incubating platelets with antibodies against PAR4 or the PAR4-specific inhibitor pepducin P4pal-i1 abolished the aggregation. Furthermore, platelets pre-exposed to the PAR4-activating peptide AYPGKF, but not to the PAR1-activating peptide SFLLRN, were aggregated by epinephrine, whereas both AYPGKF and SFLLRN synergized with epinephrine in the absence of aspirin. The roles of released ATP and ADP were elucidated by using antagonists of the purinergic receptors P2X(1), P2Y(1), and P2Y(12) (i.e. NF449, MRS2159, MRS2179, and cangrelor). Intriguingly, ATP, but not ADP, was required for the epinephrine/thrombin-induced aggregation. In Western blot analysis, a low concentration of AYPGKF, but not SFLLRN, stimulated phosphorylation of Akt on serine 473. Moreover, the phosphatidyl inositide 3-kinase inhibitor LY294002 antagonized the effect of epinephrine combined with thrombin or AYPGKF. Thus, in aspirin-treated platelets, PAR4, but not PAR1, interacts synergistically with alpha(2A)-adrenergic receptors, and the PI3-kinase/Akt pathway is involved in this cross-talk. Furthermore, in PAR4-pretreated platelets, epinephrine caused dense granule secretion, and subsequent signaling from the ATP-gated P2X(1)-receptor and the alpha(2A)-adrenergic receptor induced aggregation. These results suggest a new mechanism that has ATP as a key element and circumvents the action of aspirin on epinephrine-facilitated PAR4-mediated platelet activation.

Nyckelord

MEDICINE
MEDICIN

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy